EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting molecular pathways to control immune checkpoint inhibitor toxicities

Robin Reschke, Ryan J Sullivan, Evan J Lipson, Alexander H Enk, Thomas F Gajewski, Jessica C Hassel

Trends in Immunology · 2025-01 · 46 (1) · 61-73

DOI: 10.1016/j.it.2024.11.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2025-01. Verfasst von Robin Reschke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partners…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Immunotherapy, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Heidelberg University Medical Faculty Heidelberg, Universität Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsImmunotherapyDrug-Related Side Effects and Adverse ReactionsHumansAnimalsSignal TransductionCytokines

Stichwörter der Autor:innen

immune-related adverse eventsimmunotherapypersonalized medicinetargeted therapytoxicities

Substanzen

Immune Checkpoint InhibitorsCytokines

Autor:innen und Institutionen

  • Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germa…
  • Mass General Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.
  • Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60612, USA; Department of Pathology, University of Chicago, Chicago, IL 60637, USA. Electronic address: tgajewsk@bsd.uchicago.ed…

Förderung

  • NCI NIH HHS
  • Heidelberg University Medical Faculty Heidelberg
  • Universität Heidelberg
  • Deutsche Krebshilfe

Zitieren

APA

Reschke, R., Sullivan, R. J., Lipson, E. J., Enk, A. H., Gajewski, T. F., & Hassel, J. C. (2025). Targeting molecular pathways to control immune checkpoint inhibitor toxicities. Trends in Immunology, 46(1), 61-73. https://doi.org/10.1016/j.it.2024.11.014

Vancouver

Reschke R, Sullivan RJ, Lipson EJ, Enk AH, Gajewski TF, Hassel JC. Targeting molecular pathways to control immune checkpoint inhibitor toxicities. Trends in Immunology. 2025;46(1):61-73. doi:10.1016/j.it.2024.11.014

BibTeX
@article{Reschke2025,
  author = {Reschke, Robin and Sullivan, Ryan J and Lipson, Evan J and Enk, Alexander H and Gajewski, Thomas F and Hassel, Jessica C},
  title = {Targeting molecular pathways to control immune checkpoint inhibitor toxicities},
  journal = {Trends in Immunology},
  year = {2025},
  volume = {46},
  number = {1},
  pages = {61--73},
  doi = {10.1016/j.it.2024.11.014}
}
Kostenlos starten →